BCG-DNA对哮喘小鼠气道反应性和气道炎症的影响

doi:10.3969/j.issn.1000-8535.2017.01.001

广州医药 ›› 2017, Vol. 48 ›› Issue (1): 1-4.DOI: 10.3969/j.issn.1000-8535.2017.01.001

• 论著 • 下一篇

BCG-DNA对哮喘小鼠气道反应性和气道炎症的影响

李斌恺¹, 赖克方², 沈璐², 王法霞²

1 广州市第一人民医院老年呼吸科 (广州 510180)
2 广州医科大学第一附属医院,广州呼吸疾病研究所(广州 510120)

收稿日期:2016-11-08 发布日期:2021-12-01
通讯作者: 赖克方,E-mail:klai@163.com

The effects of Bacille Calmette-Guerin's extracts on airway inflammation and airway hyperresponsiveness in asthmatic mouse model

LI Binkai¹, LAi Kefang^2*, SHEN Lu², WANG Faxia²

1 Department of Geriatrics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, China
2 The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Diseases, Guangzhou 510120, China

Received:2016-11-08 Published:2021-12-01

摘要/Abstract

摘要： 目的观察不同剂量卡介苗核酸(Bacille Calmette-guerin DNA , BCG-DNA)在不同干预时间对哮喘小鼠气道高反应性及气道炎症的干预作用。方法 1.将Balb/c雌鼠随机分为哮喘模型组、NS对照组、BCG- DNA干预组。干预组根据干预的时间和干预制剂剂量的不同分为-7DNA1 μg、-7DNA10 μg、-7DNA100 μg、10DNA1 μg、10DNA10 μg、10DNA100 μg、17DNA1 μg、17DNA10 μg、17DNA100 μg组。2.在末次激发48小时后,测定各浓度级乙酰甲胆碱激发下的增强的呼气间歇 (Enhanced Pause, Penh)值,将其与小鼠激发前吸入NS后的Penh的百分比(Penh%NS),作为其气道反应性评价指标;其次对肺泡灌洗液进行细胞学分析。结果 1.气道反应性:①-7DNA1 μg组从Mch为3.12～50 mg/mL之间的Penh%NS显著低于哮喘组(P<0.05);②-7DNA10 μg组和-7DNA 100 μg组从Mch为6.25～25 mg/mL之间的Penh%NS显著低于哮喘组(P<0.05);③10DNA10 μg组从Mch为12.5～25 mg/mL之间的Penh%NS显著低于哮喘组(P<0.05);④10DNA100 μg组从Mch为3.12、12.5～50 mg/mL之间的Penh%NS显著低于哮喘组(P<0.05);⑤17DNA1 μg组在Mch为3.12、12.5 mg/mL的Penh%NS显著低于哮喘组(P<0.05);⑥17DNA10 μg组在Mch为12.5 mg/mL之间的Penh%NS显著低于哮喘组(P<0.05) 2.气道炎症:10DNA1 μg、-7DNA10 μg、10DNA10 μg和17DNA10 μg组的BALF细胞分类Eos%分别为:35.34±3.81、27.30±6.91、38.20±6.56、42.17±5.17;显著低于哮喘组的Eos%(48.8±6.12)(P<0.05);10DNA1 μg组的Eos%显著低于-7DNA1 μg组的Eos%(P<0.05);-7DNA10 μg组的Eos%显著低于10DNA10 μg、17DNA10 μg、-7DNA1 μg和-7DNA100 μg组的Eos%(P<0.05)。结论 BCG-DNA能降低哮喘小鼠的气道高反应性,减轻哮喘小鼠的气道炎症,早期(－7 d)中小剂量的干预效果较佳。

关键词: 支气管哮喘, 卡介苗, 核酸, 气道高反应性, 气道炎症

Abstract: Objective To investigate the effect of Bacille Calmette-Guerin BCG-DNA on airway hyperresponsiveness and airway inflammation in asthmatic mouse model. Methods 1.According to different intervention, mouse were divided into asthma groups, NS control group, BCG-DNA group. According to different time and dosage intervened with asthma model, the BCG-DNA group were subdivided into -7DNA1 μg、-7DNA10 μg、-7DNA100 μg、10DNA1 μg、10DNA10 μg、10DNA100 μg、17DNA1 μg、17DNA10 μg and 17DNA100 μg group. 2.48 hours after the final incitation, the mice were stimulated with increasing concentrations of methacholine, and the airway resistance was measured. Enhance pause (Penh) was taken for each group. Bronchoalveolar lavage cytology was performed to evaluate the airway inflammation. Results 1.Airway hyperresponsiveness: ① Penh%NS of-7DNA1 μg group was significantly lower than the asthma group when Mch was 3.12~50 mg/mL (P<0.05); ② Penh%NS of -7DNA10 μg group and -7DNA100 μg group were significantly lower than the asthma group when Mch was 6.25~50 mg/mL (P<0.05);③ Penh%NS of 10DNA10 μg group was significantly lower than the asthma group when Mch was 12.5~25 mg/mL (P<0.05); ④ Penh%NS of 10DNA100 μg group was significantly lower than the asthma group when Mch was 3.12,12.5~50 mg/mL (P<0.05); ⑤ Penh%NS of 17DNA1 μg group was significantly lower than the asthma group when Mch was 3.12 or 12.5 mg/mL (P<0.05);⑥Penh%NS of 17DNA10 μg group was significantly lower than the asthma group when Mch was 12.5 mg/mL(P<0.05). 2.Airway inflammation: The Eos% of 10DNA1 μg, -7DNA10 μg,10DNA10 μg and 17DNA10 μg group (35.34±3.81、27.30±6.91、38.20±6.56、42.17±5.17) were lower than the asthma group (P<0.05); The Eos% of 10DNA1 μg group was lower than the -7DNA1 μg group (P<0.05); The Eos% of -7DNA10 μg group was lower than the 10DNA10μg, 17DNA10 μg,-7DNA1 μg and -7DNA100 μg group (P<0.05). Conclusion BCG-DNA can inhibit the airway inflammation and hyperresponsiveness in asthmatic mouse model. Early interventions with middle dose bring better results.

Key words: Asthma, Bacille Calmette-Guerin BCG, DNA, Airway hyperresponsiveness, Airway inflammation

李斌恺, 赖克方, 沈璐, 王法霞. BCG-DNA对哮喘小鼠气道反应性和气道炎症的影响[J]. 广州医药, 2017, 48(1): 1-4.

LI Binkai, LAi Kefang, SHEN Lu, WANG Faxia. The effects of Bacille Calmette-Guerin's extracts on airway inflammation and airway hyperresponsiveness in asthmatic mouse model[J]. Guangzhou Medical Journal, 2017, 48(1): 1-4.

参考文献

[1] WHITE A D,SARFAS C,WEST K,et al.Evaluation of the immunogenicity of mycobacterium bovis BCG delivered by aerosol to the lungs of macaques[J]. Clin Vaccine. Immunol,2015,22(9):992-1003.
[2] 加慧,薄建萍,刘晨涛,等.卡介苗对支气管哮喘大鼠气道重塑的作用及机制[J]. 中华医学杂志, 2014,94(8):617-621.
[3] TANIGUCHI K,MIYATAKE Y,HAYASHI D,et al. Early-shared Mycobacterium bovis bacillus Calmette-Guerin sub-strains induce Th1 cytokine production in vivo[J]. Microbiol Immunol, 2015,59(11):684-689.
[4] KIM D H, MOON C,OH S S, et al. Liposome-encapsulated CpG enhances antitumor activity accompanying the changing of lymphocyte populations in tumor via intratumoral administration[J]. Nucleic Acid Ther, 2015,25(2):95-102.
[5] LI H T,ZHANG T T, CHEN Z G, et al. Intranasal administration of CpG oligodeoxynucleotides reduces lower airway inflammation in a murine model of combined allergic rhinitis and asthma syndrome[J]. Int Immunop harmacol, 2015,28(1):390-398.
[6] BALLESTER M, JEANBART L, de TITTA A, et al. Nanoparticle conjugation enhances the immunomodulatory effects of intranasally delivered CpG in house dust mite-allergic mice[J]. Sci Rep, 2015 ,21(5):14274.
[7] ANDERSEN P, WOODWORTH J S. Tuberculosis vaccines-rethinking the current paradigm[J]. Trends Immunol,2014,35(8):387-395.
[8] PARK S S,HEO E Y, KIM D K, et al. The Association of BCG Vaccination with Atopy and Asthma in Adults[J]. Int J Med Sci, 2015,12(8):668-673.
[9] KIRALY N, ALLEN K J, CURTIS N. BCG for the prevention of food allergy-exploring a new use for an old vaccine[J]. Med J Aust, 2015,202(11):565-566.
[10] WANG Y,YANG M,YU Q,et al. Recombinant bacillus Calmette-Guérin in urothelial bladder cancer immunotherapy:current strategies[J]. Expert Rev Anticancer Ther, 2015,15(1):85-93.

BCG-DNA对哮喘小鼠气道反应性和气道炎症的影响

The effects of Bacille Calmette-Guerin's extracts on airway inflammation and airway hyperresponsiveness in asthmatic mouse model

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 8

编辑推荐

Metrics

本文评价

[1]	高磊, 赵梅, 高文杰. 献血者HBV核酸检测非重复反应性确认及追踪结果分析[J]. 广州医药, 2021, 52(5): 83-87.
[2]	温雅, 杜焰家, 黄娟, 张伟强. 痰TB-DNA、分枝杆菌核酸、涂片找抗酸杆菌及血T-SPOT.TB试验对肺结核的诊断价值研究[J]. 广州医药, 2021, 52(2): 80-83.
[3]	姚川. M胆碱受体阻断剂联合沙丁胺醇对支气管哮喘急性发作患儿症状改善及肺功能的影响[J]. 广州医药, 2021, 52(1): 130-133.
[4]	黄育涛, 蔡幸生, 朱勇斌. 肺炎支原体RNA-SAT对儿童社区获得性肺炎诊治的价值[J]. 广州医药, 2020, 51(6): 94-97.
[5]	陈红霞. ELISA联合NAT技术在献血者血液筛查和输血残余风险分析中的应用[J]. 广州医药, 2020, 51(6): 117-119.
[6]	刘文霞, 张晓. 阿莫西林克拉维酸钾干混悬剂(7:1)联合胸腺肽治疗支气管哮喘合并肺部感染患儿的疗效[J]. 广州医药, 2020, 51(3): 136-138.
[7]	聂湘辉, 刘丽华, 胡莅鸿. ChiTaS BSS1200血液核酸检测系统的分析性能验证[J]. 广州医药, 2016, 47(4): 68-69.
[8]	吴德泰, 肖红, 相英, 朱向阳. 布地奈德对支气管哮喘患者气道重塑及肺功能影响的疗效评价[J]. 广州医药, 2015, 46(3): 31-32.